How often does Australian Clinical Labs pay dividends? What is the dividend yield for Australian Clinical Labs?

Australian Clinical Labs declared a Interim dividend on Wednesday, March 27th. Stockholders of record on Thursday, April 25th will be paid a dividend of 0.03 per share on Thursday, April 25th. This represents a dividend yield of 1.1%. The ex-dividend date of this dividend is Wednesday, March 27th. Read our dividend analysis for ACL .

Is Australian Clinical Labs a good dividend stock?

Australian Clinical Labs (ASX:ACL) pays an annual dividend of A$0.10 per share and currently has a dividend yield of 3.72%. The dividend payout ratio is 125.00%. Payout ratios above 75% are not desirable because they may not be sustainable. Read our dividend analysis for ACL .

ASX:ACL

Australian Clinical Labs (ACL) Stock Price, News & Analysis

→ Bitcoin Rockets To Record High But Buy THIS Instead (From Paradigm Press) (Ad)

Free ACL Stock Alerts

Compare

Today's Range: N/A
50-Day Range: N/A
52-Week Range: N/A

Volume: N/A
Average Volume: N/A
Market Capitalization: N/A

P/E Ratio: N/A
Dividend Yield: 3.72%
Price Target: N/A

Stock Analysis

Get Australian Clinical Labs alerts:

Ad DTI

Biden’s $374B Giveaway Into This Sector

Biden’s Climate Bill Could Send Your Retirement Accounts Soaring – Or Diving See what this $374B giveaway could mean for your retirement right here

Click here for the full story

About Australian Clinical Labs Stock (ASX:ACL)

Australian Clinical Labs Limited provides pathology services in Australia. The company offers range of services, which include routine pathology test, advanced molecular genetics testing, harmony NIPT and first trimester screening, genetic carrier screening, chemical pathology, histopathology, and cytopathology; hematology, allergy, and immunology; serology and microbiology; and infectious molecular testing, cardiac testing services, functional pathology, veterinary pathology, and commercial drug and alcohol testing services. It offers its service to private and public hospitals. Australian Clinical Labs Limited was incorporated in 2020 and is headquartered in Clayton, Australia.

Ad DTI

Biden’s $374B Giveaway Into This Sector

Biden’s Climate Bill Could Send Your Retirement Accounts Soaring – Or Diving See what this $374B giveaway could mean for your retirement right here

Click here for the full story

ACL Stock News Headlines

April 18, 2024 | morningstar.com

Australian Clinical Labs Ltd

April 2, 2024 | au.news.yahoo.com

Truth Social made 1000 times less money than X last year

April 19, 2024 | InvestorPlace (Ad)

Now Open: Crypto emergency update

During the event on Tuesday, April 23 at 10 am ET, I’ll be giving away the name and ticker symbol of crypto that could surge in price. I believe it will be the best performing crypto of 2024.

March 31, 2024 | sg.finance.yahoo.com

Is It Too Late To Consider Buying Australian Clinical Labs Limited (ASX:ACL)?

March 27, 2024 | au.investing.com

ASX 200 adds 0.8% as S&P 500 resets record valuations

February 18, 2024 | au.lifestyle.yahoo.com

With Twilio under activist pressure, Segment could be put up for sale

February 16, 2024 | finance.yahoo.com

Is Australian Clinical Labs Limited's (ASX:ACL) Latest Stock Performance A Reflection Of Its Financial Health?

January 20, 2024 | uk.finance.yahoo.com

Is There An Opportunity With Australian Clinical Labs Limited's (ASX:ACL) 36% Undervaluation?

April 19, 2024 | InvestorPlace (Ad)

Now Open: Crypto emergency update

During the event on Tuesday, April 23 at 10 am ET, I’ll be giving away the name and ticker symbol of crypto that could surge in price. I believe it will be the best performing crypto of 2024.

January 11, 2024 | afr.com

Why this fundie is backing ACL, Ramsay and Dexus

December 14, 2023 | msn.com

Healius shares tumble as Australian Clinical Labs intends to withdraw $1 billion offer

December 14, 2023 | msn.com

Australian Clinical Labs to withdraw $1 billion offer for Healius; stocks fall

December 14, 2023 | afr.com

ACL pulls Healius bid as ACCC blocks pathology shake-up

December 14, 2023 | news.yahoo.com

Australian regulator kills ACL's $1 billion bid for rival Healius

December 14, 2023 | ca.finance.yahoo.com

Australian Clinical Labs to withdraw its $1 billion offer to buy Healius

December 14, 2023 | marketwatch.com

Australian Clinical Labs Withdraws Takeover Offer for Healius

December 14, 2023 | reuters.com

Australian Clinical Labs to withdraw its $1 bln offer to buy Healius

November 29, 2023 | theguardian.com

Medical test company’s ‘serious and systemic failures’ led to cyber-attack, watchdog says

November 28, 2023 | afr.com

Sexual health and fertility details leaked in ACL data breach

November 23, 2023 | afr.com

ACL accuses Wylie of hiding links to independent Healius director

November 20, 2023 | afr.com

Dividend drought adds to pain for Healius shareholders

November 20, 2023 | afr.com

Healius preps $200 million equity raising; Barrenjoey on ticket

November 5, 2023 | fool.com.au

This ASX healthcare share just hit a 52-week low, is it time to buy?

November 3, 2023 | msn.com

Live: ASX jumps after Wall Street bounce, as Qantas faces shareholders and ACL faces hacking proceedings

October 30, 2023 | afr.com

Crescent Capital claims stake in clinical trials biz Walski

October 23, 2023 | finance.yahoo.com

What Does Australian Clinical Labs Limited's (ASX:ACL) Share Price Indicate?

August 12, 2023 | finance.yahoo.com

A Look At The Intrinsic Value Of Australian Clinical Labs Limited (ASX:ACL)

See More Headlines

Receive ACL Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Australian Clinical Labs and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Ex-Dividend for 4/25 Dividend: 3/27/2024
Today: 4/19/2024
Dividend Payable: 4/25/2024

Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange: ASX
Sector: Medical
Industry: Diagnostics & Research
Sub-Industry: N/A
Current Symbol: ASX:ACL
CUSIP: N/A
CIK: N/A
Web: www.clinicallabs.com.au
Phone: 61 3 9538 6777
Fax: N/A
Employees: 5,115
Year Founded: N/A

Profitability

EPS (Most Recent Fiscal Year): A$0.08
Trailing P/E Ratio: N/A
Forward P/E Ratio: N/A
P/E Growth: -0.36
Net Income: $15.43 million
Net Margins: 2.29%
Pretax Margin: N/A
Return on Equity: 9.19%
Return on Assets: 5.58%

Debt

Debt-to-Equity Ratio: 198.17
Current Ratio: 0.66
Quick Ratio: 0.53

Sales & Book Value

Annual Sales: $674.03 million
Price / Sales: 0.00
Cash Flow: N/A
Price / Cash Flow: N/A
Book Value: A$0.82 per share
Price / Book: N/A

Miscellaneous

Outstanding Shares: 201,830,000
Free Float: N/A
Market Cap: N/A
Optionable: Not Optionable
Beta: 1.14

Ten Starter Stocks For Beginners to Buy Now

Just getting into the stock market? These 10 simple stocks can help beginning investors build long-term wealth without knowing options, technicals, or other advanced strategies.

Get This Free Report

Key Executives

Ms. Melinda McGrath
CEO & Executive Director
Mr. James Davison
Chief Financial Officer
Mr. Anthony Friedli
Chief Operating Officer
Mr. Sean Jackson
Chief Information Officer
Mr. Joe Geran
National Marketing Director
Associate Prof. Tony Landgren
National Medical Director & Chief Pathologist
Mr. Chris Brownlow
Chief Executive Officer of New South Wales & Australian Capital Territory
Ms. Shae Seymour
Chief Executive Officer of Western Australia
Mr. Eric Swayn
Chief Executive Officer of South Australia & Northern Territory
Ms. Eleanor Padman B.A.
FCIS, Company Secretary

Key Competitors

View All Competitors

Insiders

Christine Bartlett
Bought 20,000 shares on 2/28/2024
Total: $47,160.00 ($2.36/share)

ACL Stock Analysis - Frequently Asked Questions

How often does Australian Clinical Labs pay dividends? What is the dividend yield for Australian Clinical Labs?: Australian Clinical Labs declared a Interim dividend on Wednesday, March 27th. Stockholders of record on Thursday, April 25th will be paid a dividend of 0.03 per share on Thursday, April 25th. This represents a dividend yield of 1.1%. The ex-dividend date of this dividend is Wednesday, March 27th.
Read our dividend analysis for ACL.
Is Australian Clinical Labs a good dividend stock?: Australian Clinical Labs (ASX:ACL) pays an annual dividend of A$0.10 per share and currently has a dividend yield of 3.72%. The dividend payout ratio is 125.00%. Payout ratios above 75% are not desirable because they may not be sustainable.
Read our dividend analysis for ACL.

This page (ASX:ACL) was last updated on 4/19/2024 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial